Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease

CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease

(2012) Karin Westin et al.   PLoS One

Chemokines in CSF of Alzheimer's disease patients

(2011) Jôice Dias Corrêa et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration

(2011) Massimiliano M. Corsi et al.   BIOGERONTOLOGY

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

(2011) Paul Hollingworth et al.   NATURE GENETICS

Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment

(2009) Francesca Mangialasche et al.   AGEING RESEARCH REVIEWS

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

(2009) Jean-Charles Lambert et al.   NATURE GENETICS

Monocyte Chemoattractant Protein-1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease

(2008) Anna Sokolova et al.   BRAIN PATHOLOGY

Elevated Plasma Levels of α -1-Anti-Chymotrypsin in Age-Related Cognitive Decline and Alzheimers Disease: A Potential Therapeutic Target

(2008) E. Porcellini et al.   CURRENT PHARMACEUTICAL DESIGN

Multivariable network associated with cognitive decline and dementia

(2008) Federico Licastro et al.   NEUROBIOLOGY OF AGING

Mechanisms of microglia accumulation in Alzheimer’s disease: therapeutic implications

(2008) Joseph El Khoury et al.   TRENDS IN PHARMACOLOGICAL SCIENCES